Iovance Biotherapeutics, Inc.
IOVA NASDAQHealthcare ★★★★★Latest Earnings FY2026 Q3 Above forecast↑
Date
Nov 5, 2026
ET
EPS Est.
-0.08
EPS Actual
-0.05
Revenue Est.
$116M
Revenue Actual
$121.5M
The next earnings date has not been announced yet; it is usually confirmed within weeks after the fiscal quarter ends.
Company Overview
Iovance Biotherapeutics, Inc. (ticker IOVA) is listed on NASDAQ with a market cap of about $6.38B. In the last 16 reported quarters, EPS beat consensus estimates 9 times.
Actual EPS TrendRecently16Term · Feb 28, 2023 → FY2026 Q3
Feb 28, 2023Range: -0.64 ~ -0.05FY2026 Q3
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Nov 5, 2026 | FY2026 Q3 | -0.08 | Above forecast↑-0.05 | $116M | $121.5M |
| Aug 6, 2026 | -- | -0.13 | Above forecast↑-0.11 | $87.8M | $99.3M |
| May 7, 2026 | -- | -0.19 | -0.19 | $77.8M | $71.4M |
| Feb 24, 2026 | -- | -0.22 | Above forecast↑-0.18 | $80.7M | $86.7M |
| Nov 6, 2025 | -- | -0.29 | Above forecast↑-0.25 | $82.2M | $67.5M |
| Aug 7, 2025 | -- | -0.29 | Below forecast↓-0.33 | $78.3M | $60M |
| May 8, 2025 | -- | -0.25 | Below forecast↓-0.36 | $82.4M | $49.3M |
| Feb 27, 2025 | -- | -0.26 | -0.26 | $72.2M | $73.7M |
| Nov 7, 2024 | -- | -0.31 | Above forecast↑-0.28 | $71.6M | $58.6M |
| Aug 8, 2024 | -- | -0.37 | Above forecast↑-0.34 | $24.6M | $31.1M |
| May 9, 2024 | -- | -0.45 | Above forecast↑-0.42 | $2.1M | $715000 |
| Feb 28, 2024 | -- | -0.44 | Below forecast↓-0.45 | $1.4M | $482000 |
| Nov 7, 2023 | -- | -0.46 | -0.46 | $1.7M | $469000 |
| Aug 8, 2023 | -- | -0.81 | Above forecast↑-0.47 | $3.6M | $238000 |
| May 9, 2023 | -- | -0.84 | Above forecast↑-0.50 | $200000 | -- |
| Feb 28, 2023 | -- | -0.64 | -0.64 | -- | -- |
Original Filings (SEC)
Quarterly10-Q · 2026-11-05 ↗
Earnings Release8-K · 2026-11-05 ↗
Quarterly10-Q · 2026-08-06 ↗
Earnings Release8-K · 2026-08-06 ↗
Earnings Release8-K · 2026-05-07 ↗
Quarterly10-Q · 2026-05-07 ↗
Annual10-K · 2026-02-24 ↗
Earnings Release8-K · 2026-02-24 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
